Antiproliferative Activity of Male and Female Maclura pomifera Extracts in ER-positive Breast Cancer Cell Lines

被引:0
|
作者
Rumpa, M. [1 ]
Maier, C. [1 ]
机构
[1] Texas Womans Univ, Biol, Denton, TX USA
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
B225/P1218
引用
收藏
页码:132 / 132
页数:1
相关论文
共 50 条
  • [21] Frequency and Significance of Basal Phenotype in ER-positive Breast Cancer
    Meyer, Anne-Sophie
    Kriegsmann, Mark
    Waldburger, Nina
    Jung, Audrey
    Behrens, Sabine
    Chang-Claude, Jenny
    Sinn, Hans-Peter
    [J]. MODERN PATHOLOGY, 2018, 31 : 91 - 91
  • [22] Stereotactic radiotherapy for oligoprogressive ER-positive breast cancer (AVATAR)
    Alomran, Reem
    White, Michelle
    Bruce, Melissa
    Bressel, Mathias
    Roache, Susan
    Karroum, Lama
    Hanna, Gerard G.
    Siva, Shankar
    Goel, Shom
    David, Steven
    [J]. BMC CANCER, 2021, 21 (01)
  • [23] Exhausted T cell signature predicts immunotherapy response in ER-positive breast cancer
    Manuela Terranova-Barberio
    Nela Pawlowska
    Mallika Dhawan
    Mark Moasser
    Amy J. Chien
    Michelle E. Melisko
    Hope Rugo
    Roshun Rahimi
    Travis Deal
    Adil Daud
    Michael D. Rosenblum
    Scott Thomas
    Pamela N. Munster
    [J]. Nature Communications, 11
  • [24] Targeting estrogen to kill ER-positive and ER-negative breast cancer
    Jordan, VC
    [J]. BREAST CANCER RESEARCH, 2005, 7 (Suppl 2) : S4 - S4
  • [25] Targeting estrogen to kill ER-positive and ER-negative breast cancer
    VC Jordan
    [J]. Breast Cancer Research, 7
  • [26] The prognostic effects of somatic mutations in ER-positive breast cancer
    Griffith, Obi L.
    Spies, Nicholas C.
    Anurag, Meenakshi
    Griffith, Malachi
    Luo, Jingqin
    Tu, Dongsheng
    Yeo, Belinda
    Kunisaki, Jason
    Miller, Christopher A.
    Krysiak, Kilannin
    Hundal, Jasreet
    Ainscough, Benjamin J.
    Skidmore, Zachary L.
    Campbell, Katie
    Kumar, Runjun
    Fronick, Catrina
    Cook, Lisa
    Snider, Jacqueline E.
    Davies, Sherri
    Kavuri, Shyam M.
    Chang, Eric C.
    Magrini, Vincent
    Larson, David E.
    Fulton, Robert S.
    Liu, Shuzhen
    Leung, Samuel
    Voduc, David
    Bose, Ron
    Dowsett, Mitch
    Wilson, Richard K.
    Nielsen, Torsten O.
    Mardis, Elaine R.
    Ellis, Matthew J.
    [J]. NATURE COMMUNICATIONS, 2018, 9
  • [27] The prognostic effects of somatic mutations in ER-positive breast cancer
    Obi L. Griffith
    Nicholas C. Spies
    Meenakshi Anurag
    Malachi Griffith
    Jingqin Luo
    Dongsheng Tu
    Belinda Yeo
    Jason Kunisaki
    Christopher A Miller
    Kilannin Krysiak
    Jasreet Hundal
    Benjamin J Ainscough
    Zachary L. Skidmore
    Katie Campbell
    Runjun Kumar
    Catrina Fronick
    Lisa Cook
    Jacqueline E. Snider
    Sherri Davies
    Shyam M. Kavuri
    Eric C. Chang
    Vincent Magrini
    David E. Larson
    Robert S Fulton
    Shuzhen Liu
    Samuel Leung
    David Voduc
    Ron Bose
    Mitch Dowsett
    Richard K. Wilson
    Torsten O. Nielsen
    Elaine R Mardis
    Matthew J. Ellis
    [J]. Nature Communications, 9
  • [28] Stereotactic radiotherapy for oligoprogressive ER-positive breast cancer (AVATAR)
    Reem Alomran
    Michelle White
    Melissa Bruce
    Mathias Bressel
    Susan Roache
    Lama Karroum
    Gerard G. Hanna
    Shankar Siva
    Shom Goel
    Steven David
    [J]. BMC Cancer, 21
  • [29] Anti-cancer stem cell activity of the hedgehog inhibitor GANT61 in ER-positive breast cancer cells
    Kurebayashi, J.
    Koike, Y.
    Ohta, Y.
    Saitoh, W.
    Yamashita, T.
    Kanomata, N.
    Moriya, T.
    [J]. BREAST, 2017, 32 : S39 - S39
  • [30] Attenuation of ER expression in the ER-positive breast cancer organoids by passages in vitro
    Uematsu, Hiroyuki
    Onuma, Kunishige
    Sugie, Tomoharu
    Inoue, Masahiro
    [J]. CANCER SCIENCE, 2023, 114 : 1387 - 1387